74
Views
0
CrossRef citations to date
0
Altmetric
Notes

Morushalunin D, a tri-O-bridged Diels-Alder type adduct from Morus alba var. shalun root cultures and the related precursors

ORCID Icon, ORCID Icon &
Pages 756-764 | Received 29 Mar 2023, Accepted 30 Jan 2024, Published online: 20 Feb 2024
 

Abstract

Three Diels-Alder type adducts (1-3) along with their precursors, including one 2-arylbenzofuran (4) and one stilbene (5), were isolated from the MeOH extract of M. alba var. shalun root cultures. Among them, 1 is a new Diels-Alder type adduct named morushalunin D. The molecular structures of 1-5 were elucidated based on spectroscopic data and comparison with the literatures. Cytotoxic properties of compounds 1-5 were evaluated against murine leukemia P-388 cells. Morushalunin D (1), mulberrofuran T (2), sorocein A (3), moracin M (4), and oxyresveratrol (5) were active, significantly inhibiting the growth of P-388 cells with IC50 values of 0.5, 1.0, 0.6, 2.0, and 3.3 μg/ml, respectively.

The authors gratefully acknowledge the Research Grant of P3MI 2020 from Institut Teknologi Bandung for part of financial support to this research and the Laboratory of the Integrated Chemistry, Faculty of Mathematics and Natural Sciences, ITB, for facilitating the NMR, HRMS, ECD, UV, and optical rotation measurements. We also thank and express deep gratitude to Dr. Atthar Luqman Ivansyah, Master Program in Computational Science, Faculty of Mathematic and Natural Science, Institut Teknologi Bandung for ECD spectra calculation.

Disclosure statement

No potential conflict of interest was reported by the author(s).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.